Efficacy and safety of nemtabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: Cohort J of the phase 2 BELLWAVE-003 study.

Authors: Thomas Kipps, Farrukh Tauseef Awan, Barbara Eichhorst, Yair Herishanu, Wojciech Jurczak, David Lavie, Nicolas Martinez-Calle, Andras Masszi, Carolyn Owen, Christian Poulsen, Christof Schneider, Yan Xu, Jing Yang, Mohammed Zulfiqar Husain Farooqui, Jaimal Kothari

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps7088

Source: Full article

---

Abstract

TPS7088